Journals / Medicine Science / 2019 / Cilt: 8 - Sayı: 1

The effects of nitrofurantoin on rat urinary bladder contraction

Pages
192–196
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Based on these findings, it is thought that the fact that frequent urination, which is commonly seen in UTIs, is reduced after nitrofurantoin therapy may be due to the inhibitory effect of nitrofurantoin on bladder contractions.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Nitrofurantoin is a drug used in the antibacterial treatment of urinary tract infections (UTIs) for over 60 years.
📊
Key Findings & Data:Bladder tissues obtained from male Sprague-Dawley rats were used in the study (n=24).
💡
Conclusion & Impact:Based on these findings, it is thought that the fact that frequent urination, which is commonly seen in UTIs, is reduced after nitrofurantoin therapy may be due to the inhibitory effect of nitrofurantoin on bladder contractions.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Nitrofurantoin is a drug used in the antibacterial treatment of urinary tract infections (UTIs) for over 60 years. The aim of our study was to investigate the possible effects of nitrofurantoin, which is commonly used as a urinary tract antiseptic, on bladder contractions in male rats. Bladder tissues obtained from male Sprague-Dawley rats were used in the study (n=24). After decapitation, bladder tissues were suspended in an isolated organ bath of 5 ml containing a Krebs-Ringer bicarbonate solution by applying a tension of 1.5 grams. Nitrofurantoin was administered to three groups at doses of 50, 500 and 1000 μM, respectively. The area, peak-to-peak (p-p) and frequency values of bladder contractions were analyzed before and after administration of nitrofurantoin. The data obtained from the analysis were evaluated using the Paired T-Test in the IBM SPSS Statistics Software. Nitrofurantoin was observed to have an inhibitory effect on bladder contractions at all doses. The decrease in the area and peak-to-peak values was statistically significant at all doses (P<0.05). It has been observed that nitrofurantoin inhibited bladder contractions. Based on these findings, it is thought that the fact that frequent urination, which is commonly seen in UTIs, is reduced after nitrofurantoin therapy may be due to the inhibitory effect of nitrofurantoin on bladder contractions.

🔖

Cite This Article

KAÇAR, E., ERCAN, Z., TAN, F., ZORLU, G., BULMUŞ, Ö., SERHATLIOĞLU, İ. (2019). The effects of nitrofurantoin on rat urinary bladder contraction. Medicine Science, Cilt: 8 - Sayı: 1, 192–196. https://ajindex.com/articles/277126

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Masajtis-Zagajewska A, Nowicki M. New markers of urinary tract infection. Clin Chim Acta. 2017;471:286-91.
  2. Cueto M, Aliaga L, Alós JI, et al. Executive summary of the diagnosis and treatment of urinary tract infection: Guidelines of the spanish society of clinical microbiology and infectious diseases (SEIMC). Enferm Infecc Microbiol Clin. 2017;35:314-20. Geerlings SE. Clinical presentations and epidemiology of urinary tract infections. Microbiol Spectr. 2016;4:5. Sabih A, Leslie S. Urinary tract infections, complicated. Stat pearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2017.
  3. Claussen K, Stocks E, Bhat D, et al. How common are pulmonary and hepatic adverse effects in older adults prescribed nitrofurantoin? J Am Geriatr Soc. 2017;65:1316-20.
  4. Muller AE, Verhaegh EM, Harbarth S, et al. Nitrofurantoin’s efficacy and safety as prophylaxis for urinary tract infections: a systematic review of the literature and meta-analysis of controlled trials. Clin Microbiol Infect. 2017;23:355-62.
  5. Shakti L, Veeraraghavan B. Advantage and limitations of nitrofurantoin in multi-drug resistant Indian scenario. Indian J Med Microbiol. 2015;33:47781. Busby-Whitehead JM, Johnson TM. Urinary incontinence. Clin Geriatr Med 1998;14:285-96.
  6. Robinson D, Cardozo L. Estrogens and the lower urinary tract. Neurourol Urodyn. 2011; 30: 754-7. Edwards JL. Diagnosis and management of benign prostatic hyperplasia. Am Fam Physician. 2008;77:1403-10. Buzelin JM. Female urinary incontinence. Which assessments? Which treatment?. Ann Urol. 1998;32:83-8.
  7. Van Gool J, Tanagho EA. External sphincter activity and recurrent urinary tract infection in girls. Urology. 1977;10:348-353.
  8. Ando M, Nagamatsu H, Tanizawa A, et al. Clinical analysis of urinary incontinence in the institutionalized elderly. Nihon Hinyokika Gakkai Zasshi. 1991;82:1299-304.
  9. Majeed A, Alarfaj S, Darouiche R, Mohajer M. An update on emerging therapies for urinary tract infections. Expert Opin Emerg Drugs. 2017;22:53-62.
  10. Ahmed H, Davies F, Francis N, et al. Long-term antibiotics for prevention of recurrent urinary tract infection in older adults: systematic review and metaanalysis of randomised trials. BMJ Open. 2017;7:1-7.
  11. Cunha BA, Cunha CB, Lam B, et al. Nitrofurantoin safety and effectiveness in treating acute uncomplicated cystitis (AUC) in hospitalized adults with renal insufficiency: antibiotic stewardship implications. Eur J Clin Microbiol Infect Dis. 2017;36:1213-6.
  12. Price JR, Guran LA, Gregory WT, McDonagh MS. N